Investigations conducted by researchers at The Boston Globe, the attorney general’s office and other state agencies found large academic teaching hospitals in Boston use size and reputation to command higher prices than community hospitals. For the first time, MHA publicly acknowledged in its report published Oct. 4 the trend is a systemic problem “that should be addressed.”
However, MHA President and CEO Lynn Nicholas said finding consensus among its member organizations was not easy.
“We had people who felt price variation is a huge issue and people who thought that it is being overplayed,” Ms. Nicholas told The Boston Globe.
Hospital chief executives who studied the issue for MHA represented a range of perspectives. Those who participated in the study included David Torchiana, MD, CEO of Boston-based Partners HealthCare, and Howard Grant, MD, CEO of Burlington-based Lahey Health.
More articles on finance issues:
Medical Transcription Billing makes largest acquisition since going public
Geisinger refunds patients $400k for ‘uncompassionate care’
How hospitals code superbugs has big impact on bottom line
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
